K Number
K090764
Device Name
NOVATION CFS PRESS-FIT AND CEMENTED STEMS
Manufacturer
Date Cleared
2009-04-21

(29 days)

Product Code
Regulation Number
888.3360
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
All Exactech Hip Systems are indicated for use in skeletally mature individuals undergoing primary surgery for hip replacement due to osteoarthritis, rheumatoid arthritis, osteonecrosis, post-traumatic degenerative problems of the hip, and for treatment of proximal femoral fractures where prosthetic replacement is determined by the surgeon as the preferred treatment. Components of Exactech Hip Systems are also potentially indicated for ankylosing spondylitis, congenital hip dysplasia, revision of failed previous reconstructions where sufficient bone stock is present, and to restore mobility resulting from previous fusion. Cemented femoral stems and cemented acetabular cups are intended for cemented fixation only. Press-fit femoral stems and acetabular cups are intended for press-fit fixation. Press-fit components without hydroxyapatite (HA) coating may also be used with bone cement at the discretion of the surgeon. Femoral heads and endoprostheses are intended for use in cemented and press-fit applications.
Device Description
The proposed Novation CFS Press-Fit and Cemented Femoral Stems are modifications to the existing Novation Press-Fit and Novation Cemented Plus femoral stem devices previously cleared in K042842 and K083392, respectively. The proposed Novation CFS Press-Fit stem has the same general design features as the predicate device. The modifications include the addition of a calcar collar, grit-blast body, and a satin finish neck. The proposed CFS Cemented stem has the same general design features as the Novation Cemented Plus stem, but the proposed stems are cast instead of forged cobalt chrome alloy and the neck is a satin finish. Both proposed stems contain a modified 12/14 femoral head taper connection. The proposed stems mate with previously cleared 12/14 Co-28Cr-6Mo femoral heads (K041906), Zirconia ceramic femoral heads (K050398 and K060107) and 12/14 Unipolar Sleeves (K010081). The proposed stems are not compatible with alumina ceramic femoral heads (K032964 and K051682). The predicate and proposed devices have the same intended use and basic fundamental scientific technology and share the following similarities: · the same indications for use · similar design features · incorporate the same materials · the same shelf life · are packaged and sterilized using the same materials and processes.
More Information

No
The document describes modifications to existing hip implant components and does not mention any AI or ML technology.

Yes
This device is an implantable hip system designed to treat various hip conditions, including osteoarthritis, rheumatoid arthritis, and fractures, by replacing or restoring mobility, which directly aligns with the definition of a therapeutic device.

No

This device is a hip implant system, specifically femoral stems, used in hip replacement surgery; its purpose is therapeutic, not diagnostic.

No

The device description clearly describes physical components (femoral stems, heads, sleeves) made of materials like cobalt chrome alloy and ceramic, which are hardware. There is no mention of software as the primary or sole component.

Based on the provided text, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use clearly describes a surgical implant for hip replacement. This is a device used in vivo (within the body) for treatment, not a test performed in vitro (outside the body) on biological samples to diagnose a condition.
  • Device Description: The description details physical components like femoral stems, heads, and cups, which are parts of a surgical implant.
  • Lack of IVD Characteristics: There is no mention of analyzing biological samples, reagents, calibrators, controls, or any other elements typically associated with in vitro diagnostics.

The device is a surgical implant for hip replacement.

N/A

Intended Use / Indications for Use

All Exactech Hip Systems are indicated for use in skeletally mature individuals undergoing primary surgery for hip replacement due to osteoarthritis, rheumatoid arthritis, osteonecrosis, post-traumatic degenerative problems of the hip, and for treatment of proximal femoral fractures where prosthetic replacement is determined by the surgeon as the preferred treatment. Components of Exactech Hip Systems are also potentially indicated for ankylosing spondylitis, congenital hip dysplasia, revision of failed previous reconstructions where sufficient bone stock is present, and to restore mobility resulting from previous fusion.

  • Cemented femoral stems and cemented acetabular cups are intended for cemented fixation only.
  • Press-fit femoral stems and acetabular cups are intended for press-fit fixation. Press-fit components without hydroxyapatite (HA) coating may also be used with bone cement at the discretion of the surgeon.
  • Femoral heads and endoprostheses are intended for use in cemented and press-fit applications.

Product codes (comma separated list FDA assigned to the subject device)

LWJ, LZO, JDI

Device Description

The proposed Novation CFS Press-Fit and Cemented Femoral Stems are modifications to the existing Novation Press-Fit and Novation Cemented Plus femoral stem devices previously cleared in K042842 and K083392, respectively. The proposed Novation CFS Press-Fit stem has the same general design features as the predicate device. The modifications include the addition of a calcar collar, grit-blast body, and a satin finish neck. The proposed CFS Cemented stem has the same general design features as the Novation Cemented Plus stem, but the proposed stems are cast instead of forged cobalt chrome alloy and the neck is a satin finish. Both proposed stems contain a modified 12/14 femoral head taper connection.

The proposed stems mate with previously cleared 12/14 Co-28Cr-6Mo femoral heads (K041906), Zirconia ceramic femoral heads (K050398 and K060107) and 12/14 Unipolar Sleeves (K010081). The proposed stems are not compatible with alumina ceramic femoral heads (K032964 and K051682).

The predicate and proposed devices have the same intended use and basic fundamental scientific technology and share the following similarities:

  • the same indications for use
  • similar design features
  • incorporate the same materials
  • the same shelf life
  • are packaged and sterilized using the same materials and processes.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Hip

Indicated Patient Age Range

skeletally mature individuals

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Results of engineering studies referenced in this 510(k) submission demonstrate that the proposed Novation CFS Press-Fit and Cemented Femoral Stems are substantially equivalent to the cleared predicate devices.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K042842, K083392

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

K041906, K050398, K060107, K010081, K032964, K051682

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 888.3360 Hip joint femoral (hemi-hip) metallic cemented or uncemented prosthesis.

(a)
Identification. A hip joint femoral (hemi-hip) metallic cemented or uncemented prosthesis is a device intended to be implanted to replace a portion of the hip joint. This generic type of device includes prostheses that have a femoral component made of alloys, such as cobalt-chromium-molybdenum. This generic type of device includes designs which are intended to be fixed to the bone with bone cement (§ 888.3027) as well as designs which have large window-like holes in the stem of the device and which are intended for use without bone cement. However, in these latter designs, fixation of the device is not achieved by means of bone ingrowth.(b)
Classification. Class II.

0

Exactech® Novation® CFS™ Press-Fit and Cemented Femoral Stems Special 510(k) - 510(k) Summary of Safety and Effectiveness

APR 2 1 2009

Exactech® İnc. Sponsor: 2320 N.W. 66th Court Gainesville, FL 32653

Phone: (352) 377-1140 Fax: (352) 378-2617

FDA Establishment Number 1038671

  • Tara R. Patterson Contact: Associate Regulatory Affairs Specialist
    March 18, 2008 Date:

Trade or Proprietary or Model Name(s): Exactech® Novation® CFS™ Press-Fit and Cemented Femoral Stems

Common Name: Cemented Femoral Hip Prosthesis

Press-Fit Femoral Hip Prosthesis

Classification Name:

Prosthesis, hip, semi-constrained, metal/polymer, uncemented

Prosthesis, hip, semi-constrained, metal/polymer, cemented

Prosthesis, hip, semi-constrained, metal/ceramic/polymer, cemented or non-porous, uncemented

Information on devices to which Substantial equivalence is claimed:

510(k) NumberTrade or Proprietary or Model NameManufacturer
K042842Novation® 12/14 Press-Fit Femoral StemsExactech, Inc.
K083392Novation® Cemented Plus Femoral StemsExactech, Inc.

Indications for Use:

All Exactech Hip Systems are indicated for use in skeletally mature individuals undergoing primary surgery for hip replacement due to osteoarthritis, rheumatoid arthritis, osteonecrosis, post-traumatic degenerative problems of the hip, and for treatment of proximal femoral fractures

1

K090764 (pg 2/2)

Exactech® Novation® CFSTM Press-Fit and Cemented Femoral Stems Special 510(k) - 510(k) Summary of Safety and Effectiveness

where prosthetic replacement is determined by the surgeon as the preferred treatment. Components of Exactech Hip Systems are also potentially indicated for ankylosing spondylitis, congenital hip dysplasia, revision of failed previous reconstructions where sufficient bone stock is present, and to restore mobility resulting from previous fusion.

  • . Cemented femoral stems and cemented acetabular cups are intended for cemented fixation only.
  • Press-fit femoral stems and acetabular cups are intended for press-fit fixation. Press-fit . components without hydroxyapatite (HA) coating may also be used with bone cement at the discretion of the surgeon.
  • . Femoral heads and endoprostheses are intended for use in cemented and press-fit applications.

Device Description:

The proposed Novation CFS Press-Fit and Cemented Femoral Stems are modifications to the existing Novation Press-Fit and Novation Cemented Plus femoral stem devices previously cleared in K042842 and K083392, respectively. The proposed Novation CFS Press-Fit stem has the same general design features as the predicate device. The modifications include the addition of a calcar collar, grit-blast body, and a satin finish neck. The proposed CFS Cemented stem has the same general design features as the Novation Cemented Plus stem, but the proposed stems are cast instead of forged cobalt chrome alloy and the neck is a satin finish. Both proposed stems contain a modified 12/14 femoral head taper connection.

The proposed stems mate with previously cleared 12/14 Co-28Cr-6Mo femoral heads (K041906), Zirconia ceramic femoral heads (K050398 and K060107) and 12/14 Unipolar Sleeves (K010081). The proposed stems are not compatible with alumina ceramic femoral heads (K032964 and K051682).

The predicate and proposed devices have the same intended use and basic fundamental scientific technology and share the following similarities:

  • · the same indications for use
  • · similar design features
  • · incorporate the same materials
  • · the same shelf life
  • · are packaged and sterilized using the same materials and processes.

Substantial Equivalence Conclusion:

Results of engineering studies referenced in this 510(k) submission demonstrate that the proposed Novation CFS Press-Fit and Cemented Femoral Stems are substantially equivalent to the cleared predicate devices.

2

DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with three stripes extending from its back, representing health and human services. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the eagle.

Public Health Service

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

APR 2 1 2009

Exactech® Inc. % Ms. Tara R. Patterson Associate Regulatory Affairs Specialist 2320 N.W. 66th Court Gainesville, FL 32653

Re: K090764

Trade/Device Name: Novation CFS Press-Fit and Cemented Stems Regulation Number: 21 CFR 888.3360 Regulation Name: Hip joint femoral (hemi-hip) metallic cemented or uncemented prosthesis Regulatory Class: Class II Product Code: LWJ, LZO, JDI Dated: March 19, 2009 Received: March 23, 2009

Dear Ms. Patterson:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate 16 ass starterior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The I ou may, attrefy missions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it If your dovied to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean r lease be actived that i Driver in that your device complies with other requirements of the Act that + Dr has intatutes and regulations administered by other Federal agencies. You must or any I occur all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical Of K F art 607), accember (21 CFR 803); good manufacturing practice requirements as set

3

forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at 240-276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please contact the CDRH/Office of Surveillance and Biometrics/Division of Postmarket Surveillance at 240-276-3464. For more information regarding the reporting of adverse events, please go to http://www.fda.gov/cdrh/mdr/.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

f.o.L Peter D. R.

Mark N. Melkerson Dep DIRECTOR
Director

MD 09/21/15

Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

4

Exactech® Novation® CFSTM Press-Fit and Cemented Femoral Stems Special 510(k) - Indications for Use

510(k) Number:

K090764(pg1/1)

Device Name: Exactech® Novation® CFS™ Press-Fit and Cemented Femoral Stems

INDICATIONS

All Exactech Hip Systems are indicated for use in skeletally mature individuals undergoing primary surgery for hip replacement due to osteoarthritis, theumatoid arthritis, osteonecrosis, post-traumatic degenerative problems of the hip, and for treatment of proximal femoral fractures where prosthetic replacement is determined by the surgeon as the preferred treatment. Components of Exactech Hip Systems are also potentially indicated for ankylosing spondylitis, congenital hip dysplasia, revision of failed previous reconstructions where sufficient bone stock is present, and to restore mobility resulting from previous fusion.

  • t Cemented femoral stems and cemented acetabular cups are intended for cemented fixation only.
  • Press-fit femoral stems and acetabular cups are intended for press-fit . fixation. Press-fit components without hydroxyapatite (HA) coating may also be used with bone cement at the discretion of the surgeon.
  • Femoral heads and endoprostheses are intended for use in cemented and . press-fit applications.

Prescription Use X (Part 21 CFR 801 Subpart D) and/or

Over-The-Counter Use (21 CFR 807 Subpart C)

Please do not write below this line - use another page if needed.

Image /page/4/Picture/13 description: The image shows a document with the title "Concurrence of CDRH, Office of Device Evaluation (ODE)". There is a signature above the text "(Division Sign-Off)". Below this is the text "Division of General, Restorative, and Neurological Devices". The 510(k) number is K090764.